275 related articles for article (PubMed ID: 27056559)
21. Gene therapy for primary immune deficiencies: a Canadian perspective.
Xu X; Tailor CS; Grunebaum E
Allergy Asthma Clin Immunol; 2017; 13():14. PubMed ID: 28261277
[TBL] [Abstract][Full Text] [Related]
22. Gene therapy and genome editing for primary immunodeficiency diseases.
Zhang ZY; Thrasher AJ; Zhang F
Genes Dis; 2020 Mar; 7(1):38-51. PubMed ID: 32181274
[TBL] [Abstract][Full Text] [Related]
23. The Primary Immune Deficiency Treatment Consortium: how can it improve definitive therapy for PID?
Cowan MJ
Expert Rev Clin Immunol; 2016 Oct; 12(10):1007-9. PubMed ID: 27454438
[No Abstract] [Full Text] [Related]
24. Gene therapy for primary immunodeficiency.
Booth C; Gaspar HB; Thrasher AJ
Curr Opin Pediatr; 2011 Dec; 23(6):659-66. PubMed ID: 21970832
[TBL] [Abstract][Full Text] [Related]
25. Gene therapy for immunodeficiency.
Candotti F
Curr Allergy Asthma Rep; 2001 Sep; 1(5):407-15. PubMed ID: 11892066
[TBL] [Abstract][Full Text] [Related]
26. Bone marrow transplantation for the treatment of immune deficiency states.
Lenarsky C; Parkman R
Bone Marrow Transplant; 1990 Dec; 6(6):361-9. PubMed ID: 1965792
[TBL] [Abstract][Full Text] [Related]
27. New frontiers in the therapy of primary immunodeficiency: From gene addition to gene editing.
Kohn DB; Kuo CY
J Allergy Clin Immunol; 2017 Mar; 139(3):726-732. PubMed ID: 28270364
[TBL] [Abstract][Full Text] [Related]
28. Gene therapy for primary adaptive immune deficiencies.
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
J Allergy Clin Immunol; 2011 Jun; 127(6):1356-9. PubMed ID: 21624615
[TBL] [Abstract][Full Text] [Related]
29. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
30. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome.
Castiello MC; Scaramuzza S; Pala F; Ferrua F; Uva P; Brigida I; Sereni L; van der Burg M; Ottaviano G; Albert MH; Grazia Roncarolo M; Naldini L; Aiuti A; Villa A; Bosticardo M
J Allergy Clin Immunol; 2015 Sep; 136(3):692-702.e2. PubMed ID: 25792466
[TBL] [Abstract][Full Text] [Related]
31. Treatment of immunodeficiency diseases by organ transplantation.
Parkman R
Prog Clin Immunol; 1977; 3():85-102. PubMed ID: 17139
[No Abstract] [Full Text] [Related]
32. Gene therapy of primary T cell immunodeficiencies.
Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
Gene; 2013 Aug; 525(2):170-3. PubMed ID: 23583799
[TBL] [Abstract][Full Text] [Related]
33. Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Amendment to clinical research project, Project 90-C-195, January 10, 1992.
Blaese RM; Culver KW; Chang L; Anderson WF; Mullen C; Nienhuis A; Carter C; Dunbar C; Leitman S; Berger M
Hum Gene Ther; 1993 Aug; 4(4):521-7. PubMed ID: 7691188
[TBL] [Abstract][Full Text] [Related]
34. Clinical applications of gene therapy for primary immunodeficiencies.
Cicalese MP; Aiuti A
Hum Gene Ther; 2015 Apr; 26(4):210-9. PubMed ID: 25860576
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow transplantation for immunodeficiency diseases.
Good RA
Am J Med Sci; 1987 Aug; 294(2):68-74. PubMed ID: 3307407
[TBL] [Abstract][Full Text] [Related]
36. Gene therapy of the immune system.
Cournoyer D; Caskey CT
Annu Rev Immunol; 1993; 11():297-329. PubMed ID: 8476564
[TBL] [Abstract][Full Text] [Related]
37. Stem cell transplantation for primary immune deficiency.
Worth AJ; Booth C; Veys P
Curr Opin Hematol; 2013 Nov; 20(6):501-8. PubMed ID: 24104410
[TBL] [Abstract][Full Text] [Related]
38. Retroviral-mediated gene transfer into mammalian cells.
Kohn DB; Kantoff PW; Eglitis MA; McLachlin JR; Moen RC; Karson E; Zwiebel JA; Nienhuis A; Karlsson S; O'Reilly R
Blood Cells; 1987; 13(1-2):285-98. PubMed ID: 3311223
[TBL] [Abstract][Full Text] [Related]
39. Gene therapy for adenosine deaminase deficiency.
Cappelli B; Aiuti A
Immunol Allergy Clin North Am; 2010 May; 30(2):249-60. PubMed ID: 20493400
[TBL] [Abstract][Full Text] [Related]
40. [Transplantation of genetically modified cells in the treatment of children with SCID: great hopes and recent disappointments].
Smogorzewska EM; Weinberg KI; Kohn DB
Med Wieku Rozwoj; 2003; 7(1):27-34. PubMed ID: 13130167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
